Patients on biologic therapy showed no difference in risk of infection with SARS-CoV-2 or mortality due to infection [Odds Ratio (OR): 0.88], and patients on anti-TNFα showed a lower incidence than the general population (OR: 0.69). This evidence concerns the gene TNF and infection.